Developing affordable technologies for cervical cancer prevention and diagnosis in women with HIV
Official title: The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
Funded at University of Tx Md Anderson Can Ctr · NIH-10895285 · Data updated 2026-11-12
The AVANÇO Research Consortium is working to find better and affordable ways to screen and treat cervical cancer for women living with HIV in low- and middle-income countries, so they can have healthier lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,059,338 |
| NIH project number | 5U54CA277843-02 |
| Project ID | NIH-10895285 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women living with HIV, particularly those in low- and middle-income countries.
✕Less likely to help
Patients who are not living with HIV or those who do not have access to the targeted regions may not benefit from this research.
What this research studies
The AVANÇO Research Consortium aims to create sustainable research programs that focus on cervical cancer screening, diagnosis, and treatment specifically for women living with HIV in low- and middle-income countries. This collaborative effort involves institutions from the US, Mozambique, and Brazil, leveraging expertise in various fields such as bioengineering and epidemiology. The research will explore innovative, low-cost methods to improve cervical cancer outcomes for this vulnerable population, addressing a significant health disparity. By establishing a robust research infrastructure, the project seeks to enhance the understanding and management of HIV-associated malignancies.
Why it matters
Potential benefit: If successful, this research could lead to improved cervical cancer prevention and treatment options for women living with HIV, ultimately saving lives.
How similar studies have gone: Previous research has shown success in developing low-cost health technologies for underserved populations, indicating potential for this approach.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Schmeler, Kathleen — University of Tx Md Anderson Can Ctr
- Study coordinator: Schmeler, Kathleen
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.